Immunopharmacology of FK-506.
Morris
R E
RE
Department of Cardiovascular Surgery, Stanford University School of Medicine, CA 94305.
Hoyt
E G
EG
Murphy
M P
MP
Shorthouse
R
R
D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004790:Enzyme Induction; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation; D006789:Host vs Graft Reaction / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D010634:Phenobarbital / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016559:Tacrolimus; D014184:Transplantation, Homologous
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D011725:Pyridines; D003577:Cytochrome P-450 Enzyme System; D016559:Tacrolimus; D010634:Phenobarbital